- Home
- LNTH vs WCC Comparison
LNTH vs WCC Comparison
Compare LNTH & WCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LNTH
- WCC
- Stock Information
- Founded
- LNTH 1956
- WCC 1922
- Country
- LNTH United States
- WCC United States
- Employees
- LNTH N/A
- WCC N/A
- Industry
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- WCC Telecommunications Equipment
- Sector
- LNTH Health Care
- WCC Consumer Discretionary
- Exchange
- LNTH Nasdaq
- WCC Nasdaq
- Market Cap
- LNTH 7.5B
- WCC 8.0B
- IPO Year
- LNTH 2015
- WCC 1999
- Fundamental
- Price
- LNTH $101.32
- WCC $151.15
- Analyst Decision
- LNTH Strong Buy
- WCC Buy
- Analyst Count
- LNTH 6
- WCC 7
- Target Price
- LNTH $129.83
- WCC $219.43
- AVG Volume (30 Days)
- LNTH 830.2K
- WCC 924.5K
- Earning Date
- LNTH 05-01-2025
- WCC 05-01-2025
- Dividend Yield
- LNTH N/A
- WCC 1.20%
- EPS Growth
- LNTH N/A
- WCC N/A
- EPS
- LNTH 4.36
- WCC 13.05
- Revenue
- LNTH $1,533,910,000.00
- WCC $21,818,800,000.00
- Revenue This Year
- LNTH $5.74
- WCC $3.45
- Revenue Next Year
- LNTH $12.27
- WCC $4.43
- P/E Ratio
- LNTH $23.24
- WCC $11.58
- Revenue Growth
- LNTH 18.32
- WCC N/A
- 52 Week Low
- LNTH $61.47
- WCC $125.21
- 52 Week High
- LNTH $126.89
- WCC $216.17
- Technical
- Relative Strength Index (RSI)
- LNTH 55.37
- WCC 46.51
- Support Level
- LNTH $91.65
- WCC $143.99
- Resistance Level
- LNTH $104.00
- WCC $153.44
- Average True Range (ATR)
- LNTH 5.54
- WCC 9.77
- MACD
- LNTH 0.34
- WCC 1.09
- Stochastic Oscillator
- LNTH 85.89
- WCC 68.43
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
About WCC WESCO International Inc.
Wesco International is an industrial distributor that has three reportable segments, electrical and electronic solutions, communications and security solutions, and utility and broadband solutions. The company offers more than 1.5 million products to its 140,000 active customers through a distribution network of 800 branches, warehouses, and sales offices, including 43 distribution centers. Wesco generates approximately 74% of its sales in the United States, but it has a global reach, with operations in 50 other countries.